Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database

MLA

Maria Antonietta Barbieri, et al. “Safety Profile of Tyrosine Kinase Inhibitors Used in Non-Small-Cell Lung Cancer: An Analysis from the Italian Pharmacovigilance Database.” Frontiers in Oncology, vol. 12, Nov. 2022. EBSCOhost, https://doi.org/10.3389/fonc.2022.1005626.

APA

Maria Antonietta Barbieri, Emanuela Elisa Sorbara, Giuseppe Cicala, Vincenza Santoro, Paola Maria Cutroneo, Tindara Franchina, Mariacarmela Santarpia, Nicola Silvestris, & Edoardo Spina. (2022). Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database. Frontiers in Oncology, 12. https://doi.org/10.3389/fonc.2022.1005626

Chicago

Maria Antonietta Barbieri, Emanuela Elisa Sorbara, Giuseppe Cicala, Vincenza Santoro, Paola Maria Cutroneo, Tindara Franchina, Mariacarmela Santarpia, Nicola Silvestris, and Edoardo Spina. 2022. “Safety Profile of Tyrosine Kinase Inhibitors Used in Non-Small-Cell Lung Cancer: An Analysis from the Italian Pharmacovigilance Database.” Frontiers in Oncology 12 (November). doi:10.3389/fonc.2022.1005626.